openPR Logo
Press release

Cancer Biomarkers Market by Top Key Players are Myriad RBM, Abbott, F. Hoffmann-La Roche Ltd., BioVision Inc., Thermo Fisher Scientific, R&D System, Bio-Rad Laboratories, Inc, Sino Biological Inc, CENTOGENE N.V, Sino Biological Inc, Axon Medchem

04-29-2020 08:22 AM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd

Cancer Biomarkers Market by Top Key Players are Myriad RBM,

The global cancer biomarkers market size is forecast to reach USD 48.20 billion by 2026 on account of the increasing popularity of personalized treatment for cancer worldwide. Biomarkers help to detect cancer at an early stage and facilitate noninvasive diagnosis at high-speed by utilizing different proteomic and genomic markers. As per a recently published report by Fortune Business insights(TM) titled, "Cancer Biomarkers Market Size, Share & Industry Analysis, By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer And Others), By Biomarker Type (PSA, HER-2, EGFR, KRAS, and others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026," the market size was USD 18.94 billion in 2018 and will exhibit a CAGR of 12.4% between 2019 and 2026.

The report covers:

Global Cancer Biomarkers Market trends, with detailed analysis on consumer trends & manufacturer trends.
Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
Key areas of investments identifying market opportunities and challenges in forecast timeframe.
Competitive analysis of the industry players along with the overview on strategic management.
Comprehensive company profiles of the major industry players.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cancer-biomarkers-market-100630

Leading Players operating in the Cancer Biomarkers Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

Myriad RBM
Abbott
Hoffmann-La Roche Ltd.
BioVision Inc.
Thermo Fisher Scientific
R&D System
Bio-Rad Laboratories, Inc.
Sino Biological Inc.
CENTOGENE N.V.
Sino Biological Inc.
Axon Medchem
Market Drivers

Rise in Prevalence of Cancer Worldwide to Augment Growth

 

The increasing prevalence of cancer is a prime factor boosting the cancer biomarkers market growth. In addition to this, the market is also witnessing a significant rise on account of the growing demand for drug discovery and development for various cancer types. Additionally, many pharmaceutical companies are investing massive amounts into research and development of novel biomarkers for cancer therapeutics. Moreover, many clinical trials and pipeline studies are currently heading towards the end stages of development, and their market entry is likely to attract high cancer biomarkers market revenue in the coming years.

On the flip side, the market may face challenges in terms of reimbursement policies supported by the governments. This is further attributed to the high cost of treatment for cancer, especially in developing nations. Nevertheless, government support in spreading awareness about cancer, and the availability of treatment options for the same are likely to create lucrative growth opportunities for the market in the forthcoming years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/cancer-biomarkers-market-100630

Regional Segmentation:

North America to Emerge Dominant Owing to Higher Adoption of Next-Generation Sequencing

 

From a geographical perspective, the global cancer biomarker market is widespread into the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Each of these regions is further categorized into nations. Among these, North America earned USD 6.88 billion in 2018 and emerged dominant owing to the high adoption personalized medicine. Europe ranks second in the market with a rising number of research studies for using biomarkers in development and discovery.

Furthermore, the market in the Asia Pacific is expected to contribute significant oncology biomarker market share on account of rising in investments for research and development of biomarkers. This, coupled with increasing support from government and private bodies for the drug development process and patient stratification.

Detailed Table of Content:

Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence/ Incidence, by Cancer Type, by Key Regional/ Countries
New Product Launches, by Key Market Players
Pipeline Analysis, Cancer Biomarkers
Key industry Developments - Mergers, Acquisitions and Partnerships
Global Cancer Biomarkers Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast - By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Others
Market Analysis, Insights and Forecast - By Biomarker Type
PSA
HER-2
EGFR
KRAS
Others
Market Analysis, Insights and Forecast - By End User
Pharmaceutical & Biotechnology Companies
Diagnostics & Research Laboratories
Hospitals & Specialty Clinics
Others
Market Analysis, Insights and Forecast - By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cancer-biomarkers-market-100630

Report Focus:

Extensive product offerings
Customer research services
Robust research methodology
Comprehensive reports
Latest technological developments
Value chain analysis
Potential Cancer Biomarkers Market opportunities
Growth dynamics
Quality assurance
Post-sales support
Regular report updates

Reasons to Purchase this Report:

Comprehensive analysis of the Cancer Biomarkers Market growth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarkers Market by Top Key Players are Myriad RBM, Abbott, F. Hoffmann-La Roche Ltd., BioVision Inc., Thermo Fisher Scientific, R&D System, Bio-Rad Laboratories, Inc, Sino Biological Inc, CENTOGENE N.V, Sino Biological Inc, Axon Medchem here

News-ID: 2028710 • Views: …

More Releases from Fortune Business Insights Pvt. Ltd

Wheat Flour Market Size, Share, Latest Trends, Top Companies and Forecast by 2028 | Ardent Mills , Wudeli Flour Mill Group, ADM Company , General Mills, Allied Pinnacle Pty Ltd., Manildra Milling Pvt. Ltd.
Wheat Flour Market Size, Share, Latest Trends, Top Companies and Forecast by 202 …
The global Wheat Flour Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Wheat Flour Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. The global wheat flour market size was USD 155.08 billion in 2020…
Vanilla Extracts Market Size, Latest Trends, Revenue, Growth, Top Companies and Forecast by 2029 | Adams Extract (U.S.), C.F. Sauer Company (U.S.), McCormick & Company (U.S.), Frontier Natural Products (U.S.), Madécasse (U.S.), Nielsen-Massey Vanillas (U
Vanilla Extracts Market Size, Latest Trends, Revenue, Growth, Top Companies and …
The global Vanilla Extracts Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Vanilla Extracts Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. The global vanilla extract market size was valued at USD 5.26 billion…
Hummus Market Share, Size, Top Companies, Latest Trends and Forecast by 2021-2028 | Nestlé S.A. (Vevey, Switzerland), Cedar's Mediterranean Foods, Inc. (Massachusetts, U.S.), Haliburton International Foods, Inc. (California, U.S.), Strauss Group, Ltd. (S
Hummus Market Share, Size, Top Companies, Latest Trends and Forecast by 2021-202 …
The global Hummus Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Hummus Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. The global hummus market size was USD 2.62 billion in 2020 and is projected…
Frozen Food Market Trends, Size, Share, Growth and Forecast by 2028 | McCain Foods, Wawona Frozen Foods, ConAgra Foods, Inc. and Nestle S.A.
Frozen Food Market Trends, Size, Share, Growth and Forecast by 2028 | McCain Foo …
The global Frozen Food Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Frozen Food Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. The global frozen food market size was USD 231.38 billion in 2020…

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…